June 11, 2024 02:31 PM EDT

NJ federal judge rules Teva inhaler patents are 'improperly listed' in Orange Book

Nicole DeFeudis

Editor

Five of Teva’s inhaler patents are “improperly listed” in the FDA’s Orange Book, a federal judge ruled Monday, in a win for Amneal Pharmaceuticals’ efforts …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

NJ federal judge rules Teva inhaler patents are 'improperly listed' in Orange Book

Nicole DeFeudis

Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

FDA cancels Applied Therapeutics adcomm, shares skyrocket 65%

Here's what today's Fed rate cut means for biotech, pharma and venture capital

All of 23andMe's independent board members resign over disagreements with CEO

Roivant makes another deal, selling Dermavant to Organon for up to $1.2B

With few efficacy details, Insilico claims a Phase 2a win in latest AI readout

Breaking down silos with a new quantitative approach to drug development

NJ fed­er­al judge rules Te­va in­haler patents are 'im­prop­er­ly list­ed' in Or­ange Book

Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

NJ federal judge rules Teva inhaler patents are 'improperly listed' in Orange Book